Skip to main content
. 2017 Dec 21;2(1):30–39. doi: 10.1016/j.mayocpiqo.2017.11.002

Table 5.

Multivariate Analysis—Predictors of a Malignant Adrenal Massa

Any malignant mass
Variable All patientsb (n=547)
Only for patients with unenhanced HU measurements availableb (n=297)
Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Sex (male vs female) 1.57 (1.04-2.37) .03c 1.45 (0.72-2.95) .29
Age at diagnosis (each decade increase) 1.2 (1.04-1.37) .01c 1.08 (0.86-1.4) .49
Mode of discovery (nonincidental vs incidental) 6.99 (4.5-10.99) <.001c 5.92 (2.7-13.4) <.001c
Adrenal mass size (each 1-cm increase) 1.2 (1.14-1.3) <.001c 1.3 (1.17-1.48) <.001c
Unenhanced CT attenuation (each 1-HU increase) 1.08 (1.06-1.1) <.001c
Other malignancy
Variable All patientsb (n=547)
Only for patients with available work-up for adrenal glucocorticoid productionb (n=393)
Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Sex (male vs female) 2.4 (1.5-3.9) .002c 1.8 (0.95-3.4) .07
Age at diagnosis (each decade increase) 1.45 (1.2-1.7) <.001c 1.6 (1.3-2.1) <.001c
Mode of discovery (nonincidental vs incidental) 7.8 (4.7-13) <.001c 5.5 (2.8-11) <.001c
Adrenal mass size (each 1-cm increase) 1.1 (0.98-1.15) .17 0.9 (0.8-1) .05c
Hypercortisolism (vs normal cortisol production) 0.2 (0.1-0.4) <.001c
ACC
Variable All patientsb (n=547)
Only for patients with available work-up for adrenal glucocorticoid productionb (n=393)
Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Sex (male vs female) 0.53 (0.29-0.95) .03c 0.79 (0.37-1.6) .52
Age at diagnosis (each decade increase) 0.83 (0.69-0.99) .04c 0.83 (0.67-1.02) .08c
Mode of discovery (nonincidental vs incidental) 2.48 (1.4-4.4) .002c 2.9 (1.4-5.9) .003c
Adrenal mass size (each 1-cm increase) 1.36 (1.27-1.47) <.001c 1.5 (1.37-1.68) <.001c
Hypercortisolism (vs normal cortisol production) 3.5 (1.7-7.6) <.001c
a

CT = computed tomography; HU = Hounsfield units.

b

Pheochromocytomas were excluded from this analysis.

c

Indicates statistical significance with P values <.05.